A detailed history of Herold Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Herold Advisors, Inc. holds 68,258 shares of PFE stock, worth $1.8 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
68,258
Previous 62,076 9.96%
Holding current value
$1.8 Million
Previous $1.74 Million 13.77%
% of portfolio
0.44%
Previous 0.41%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $171,241 - $194,052
6,182 Added 9.96%
68,258 $1.98 Million
Q2 2024

Jul 24, 2024

BUY
$25.26 - $29.6 $150,473 - $176,327
5,957 Added 10.61%
62,076 $1.74 Million
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $197,877 - $227,226
-7,643 Reduced 11.99%
56,119 $1.56 Million
Q4 2023

Feb 02, 2024

BUY
$26.13 - $33.94 $26,809 - $34,822
1,026 Added 1.64%
63,762 $1.84 Million
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $311,625 - $364,259
9,711 Added 18.31%
62,736 $2.08 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $109,588 - $126,790
3,034 Added 6.07%
53,025 $1.94 Million
Q1 2023

Apr 19, 2023

BUY
$39.39 - $51.28 $618,816 - $805,608
15,710 Added 45.83%
49,991 $2.04 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $91,015 - $118,810
2,180 Added 6.79%
34,281 $1.76 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $13,959 - $17,040
319 Added 1.0%
32,101 $1.4 Million
Q2 2022

Jul 15, 2022

SELL
$46.53 - $55.17 $78,496 - $93,071
-1,687 Reduced 5.04%
31,782 $1.67 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $22,371 - $27,721
489 Added 1.48%
33,469 $1.73 Million
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $36,485 - $54,083
883 Added 2.75%
32,980 $1.95 Million
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $1.26 Million - $1.62 Million
32,097 New
32,097 $1.38 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Herold Advisors, Inc. Portfolio

Follow Herold Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Herold Advisors, Inc. with notifications on news.